Inventor · disambiguated record
Daniel Lee Severance
Also filed as: SEVERANCE DANIEL L · SEVERANCE DANIEL LEE
10 granted patents·7 pending applications·48 citations·filing 1999–2023
88Inventor score
Files withNIMBUS SATURN INC8KALYPSYS INC2PETRA PHARMA CORP2RECURIUM IP HOLDINGS LLC2IDEAYA BIOSCIENCES INC1
Top patents by PatentIndex Score
17 records- 0197US11034694B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 15, 2021·12 cites·22 claims
- 0296US11078201B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Aug 3, 2021·7 cites·22 claims
- 0396US11028085B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 8, 2021·6 cites·22 claims
- 0496US11021481B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 1, 2021·7 cites·22 claims
- 0595US11548890B1HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2021·Granted Jan 10, 2023·3 cites·30 claims
- 0683US2024025898A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2023·Application pending·0 cites
- 0782US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 0881US11649227B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2021·Granted May 16, 2023·1 cites·20 claims
- 0972US12215105B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2020·Granted Feb 4, 2025·0 cites·18 claims
- 1071US10493060B2Spirocyclic compoundsZENO ROYALTIES & MILESTONES LLC·Filed 2019·Granted Dec 3, 2019·1 cites·11 claims
- 1166US2023286960A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 1263US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1360US2025011331A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Application pending·0 cites
- 1454US2025325552A1Substituted thiadiazolyl derivatives as dna polymerase theta inhibitorsIDEAYA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1552US2006252807A1Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disordersKALYPSYS INC·Filed 2006·Application pending·0 cites
- 1650US6335459B1Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulatorsSYNTEX LLC·Filed 1999·Granted Jan 1, 2002·9 cites·32 claims
- 1750US2007191371A1Heterocyclic modulators of pparKALYPSYS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Lee Severance files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →